Healthcare -
Biotechnology - NASDAQ - US
$ 57.18
1.35 %
$ 7.27 B
Market Cap
18.93
P/E
HALO - CASH & EQUIVALENTS
Cash & Equivalents HALO - Halozyme Therapeutics, Inc.
118 M
LAST VALUE
-0.15%
2 YEAR CAGR
15.36%
5 YEAR CAGR
15.78%
10 YEAR CAGR